Jaguar Health (JAGX) Change in Cash (2014 - 2026)
Jaguar Health (JAGX) reported Change in Cash of $2.2 million for Q1 2026, up 196.54% year-over-year from $752681.4 in Q1 2025, and down 48.15% quarter-over-quarter from $4.3 million in Q4 2025.
Jaguar Health (JAGX) Change in Cash (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Change in Cash data on file, last reported at $2.2 million in Q1 2026.
- Change in Cash for Q1 2026 came in at $2.2 million, up 196.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.4 million (up 173.13% YoY), and the FY2025 annual result was -$170000.0, down 111.09% from the prior year.
- Change in Cash eased to $2.2 million in Q1 2026 per JAGX's latest filing, from $4.3 million in the prior quarter.
- Over five years, Change in Cash peaked at $8.9 million in Q1 2023 and troughed at -$8.4 million in Q2 2022.
- A 5-year average of -$411000.0 and a median of $405000.0 in 2022 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2023: Change in Cash plunged 2397.63% in 2022, then surged 2097.04% in 2023.
- A 5-year view of Change in Cash shows it stood at -$5.1 million in 2022, then surged by 163.69% to $3.2 million in 2023, then slumped by 262.41% to -$5.3 million in 2024, then surged by 181.74% to $4.3 million in 2025, then plunged by 48.15% to $2.2 million in 2026.
- Business Quant data shows JAGX's Change in Cash at $2.2 million in Q1 2026, $4.3 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -45.97 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 2.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 4.31 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | -3.48 Mn |
| Mar 31, 2025 | -2.31 Mn |
| Dec 31, 2024 | -5.27 Mn |
| Sep 30, 2024 | -2.78 Mn |
| Jun 30, 2024 | 4.38 Mn |
| Mar 31, 2024 | 5.20 Mn |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | -5.40 Mn |
| Jun 30, 2023 | -5.74 Mn |
| Mar 31, 2023 | 8.90 Mn |
| Dec 31, 2022 | -5.09 Mn |
| Sep 30, 2022 | 1.55 Mn |
| Jun 30, 2022 | -8.44 Mn |
| Mar 31, 2022 | 405,000.00 |
| Dec 31, 2021 | 4.68 Mn |
| Sep 30, 2021 | -19.54 Mn |
| Jun 30, 2021 | -338,000.00 |